3 


  


 
    !
  " #
!$ !%& '! 
"()*"% )&(%
 
!+ ,  -+!%
(!
. .!/  )0'$.
()
/ " #%  ")!% 
  .)&(
. "%   1  )12*3 3 )./43 1.(  ".
)  " #".! 5%  ! /&-  312 /()   )
(  *6# ! 4   
  
    .  12 * 3  3/ 5 &   
   /&17) 6 (*6#  
3.1 (*6#!4
 +)%
5% 05
  
3.2 (*6#!4
  )0'$.
  
3.3 (*6#!4
 )/( (&/&(!
$.
  
3.4 (*6#!4
 ) )'%,#/&(! $.

  
3.5 (*6#!4
 
  
3.6 (*6#!4
  )/)2+
  
3.1 

 

 !"!#$%
"&'(

Good Compounding Practice for Non-Sterile Products in Hospitals

  &" 2 .3
(7% ? 1
1. 4) ( /)!+ (Non-sterile Products)
2. 05 (Sterile Products)
 
   .&
(/&-2%! + 0 1!) 1!)
5&7 ".1!)
 3/5  1!)%!)) " # 1!) )".
//2(!(2%) 3/5)  4)
   +)%!%. 
. ( 
53  .+2" (Dosage Form) 5% &5)
,# (Elixir) &"!. "1,   1) 5 (- 

 /&  (    )          %   1!)  )   "%  ."(%
 $.
.12*3   X)(*6#!4

 +)%
5% 05
   5%!
( 
  +
 % ()./) .!  .  )/Y".2*# 
5
!Y2 Z[(  )/".- !/1!)1 /3".
!/ 2 (( *&&( Beyond-use Date) 2".^$
".)* , )&( 12   %+
1. @A
1.1  1!  %
!*/..  )()./) )"/ /!% )
Y% 0  )$(% !*% (!*
(1&'"%1+
(!*)12% (( " % ( !* ) 051!
" !* ) 4)( /)!+
1.2 '*.3
 )1 1!12)2*(3) 1!)5".Z2. _ /
`a3  (Z2 %(( - (
%
!* ! +)%1!- ^ ".".% .' (((%
!* 
..&
()Z2 `a
2*#(  5% Z_ %"./ +bb_ ((% 
+)%-Z2 (/(2
(`a
1.3 )% % ) %  1 %  %
(
!*  
5&1!)
/.)%& 
1.4 )./. (   +)%) " &1!)/.
!*!  . &1!)/.%".(  21 ".2!! & 
&1!)/. ".+)%1!&1!)/.
*. 
2.
CD

2.1 12*!2c
2.1.1 3/5 )
27.!553/5)
2.1.2    3/5)(   5% ! 1!0 '. 
)4 )0'd 6  % & (%)3/5   )12*/)".

1!)()./) /)Y&(+)() )1!)

".5
 
X+
2.2  3/5) 1!+Z[/ 3/5  %
% Z [/.!
2.2.1 Z[
51 ) 5 5% 1 5 ".1 !
2.2.2 Z[11 3/5) 5% /) (Levigation) 
/) (Trituration) /)" Geometric Dilution
2.2.3 /12*/) 
"% ? ".i  ! 5%
1!)1 !".-'
2.2.4 1&!* 3/5)
!4Z[/ &+   /4 ".Z[X % %  )
/./ .).)Z[X '*.  ".
/ 
2.3 "% 
1!"%   ! /     / . ".)  _    `a  ! !.
%  5% )
( )"." *. !)_  ."%
! !.(%! )".&
"%   
2.3.1
/%/12)/. *
5/1) 1!/!)"!% Y2 )
( ".12) 
2.3.2 )" () . (
 (1% ?
, &
(1!)/ ( %  1!" 3/51!12) )_ 
(
(  "!"%*
2.4 /23)   
2.4.1 (X  . )/23)  ".+!
/23 %  d. 1 1
2.4.2 1!))  !/23) /%!211  $.
 %  (&  )  

2.4.3  /!)52X /.%j%5 ()./) X

!)Y ()!12)) ^ Y2 ) )1!)&
2.4.4 (1% ()"^!*!(  % 
()X  !  ) 
3. D&( &(EF(C#

3/55
&( 5".12*'*. ( &75 5
&/ &(!4
5 "."'1 ) 2*#
5
 

   , &(+!

*6#)k.2 3)". 3) )k
3/5) .! /4*/2
3.1 1 5 1! %
)1!)5& ! .)1 +)%1+(!
% ".(% 5% )() 1!)!/31 5 .&2d
( %

/3 ".)/+!! 
5"! !/1 5

Remingtonms Pharmaceutical Sciences, The United States Pharmacopoeia-The
National Formulary (USP-NF) ( USP DI Volume III: Approved Drug Products and
Legal Requirements 1!!/&(&/2/)Y5 + 1 5 
5 5
&(/)* ? 1!
51 5 +! (Sensitive) Y 5 &(/
&!%1%&/25 + 1!
5!4 Aliquot
5
3.2 1 ! 
51 !  % ()./) 1!
5.! 
%    (  )!%   ) /   !  -     
(    1!)")%  & 
(Accuracy) )/2 ( % ? 1 +)%1!! )/ !% 20%  )
.! Y/() 5% Glycerol (Glycerin) ( Mineral Oil  %
(+(
.!
(() (
5!45  1&!*1!)Y%! &. (Specific Gravity)
 /" Y/ ! )) )
5 Micropipets  !+1!)^
/ Y /)5/)Y! /+.(!% 10 +)1 Y 5 )
.! 1 (Conical Cylinder)
5&! 1!)/.!
/)/
! !  "%)1!)")% & !%.! ".+)%1!
5.! 1)
) !% 25 ).

3.3 2*#/)( )  1!)% 2 .3 1  % "! ". %

Porcelain ( Wedgwood % "!
5// (Stain) () (Oily) ".
5 )/
.3 Antineoplastic Agent /&(% Porcelain )!( !%
5

/)  ( +)%
(.
!*/)  ).'5  %   ) Spatula ( 
(
5
(Spatula -!% 6 !
5/) "( 
(7%!% 6 !
5/)1)( )*
)) ). (Slab ( Tile) /) )2*#()./) 5% ! .'
# "% "!1 +bb_  - "."5%"- 
4. (D#F
(
H(I

4.1. /1)/! /&17 ".! 5%!
4.1.1  )k)&  (Pharmacopoeia)  )(
5
5  )
 1!)/24 (Certificate of Purity) &)! ".,
"(% ,5Y+
4.1.2
*" #+)%.2" (Dosage Form)  
( ) ".

(3/5&( 1!

5/1)
(/1 "   i 
&)
5
"  +"%
. 12*/)  31) ". 3 ! /&17
. " 
(./43/ /2
1. .!! 5%  2 "./3!. ! ()/(+)%)
. '*.1 '
. 1!)/.!

(  ".
5  !
" . )"! ! ?  
. Y/1)
& (! .
" &
5% &
/ &5) ( ,#
. Y/1)
&( 
"  "%
2 (Divided Powders) 5% , ( "1,
1. Y/1)
&  (!". "(  &
/
&"!. ,# ( )5

4.2 .34 (Extended Release ( Delayed Release) +)%1!

&)
5 ! /&17
4.3 $ Y! /&17 $1!!/5  (. 5
 Prodrugs , .+)%4)
(
" 5% .) 1!)1 !
! 
& % ( First Past Effect ".1!)%. Y "( 
5$ 
.! !% 2 ! ./)
5. # 
&()*
"%.1 .)k".1!)) "%.
    !+.)* 

/  ".1!)1 ! Y++1!&
!!1.(# 1)
()
!% )12*3/)&/)".)1!)1 ! ))
 " 5 /(!4 ) 1!&!1.(#,&1 
!1.(#".-+!. .!+)% !%!&(
-
/  % 
6. HL(DF 


)  )
/
(    
   1!!/!%  )    3 * 6# 5   
&(%
 (+)% Y)&(% !!% /
&"%  (+)%
Y!/"!!% 3*6# &(% )/% ? ()./)1
5' 1!)
) /()./) 12*/) 1)  3 "../43
' )
1!)  / % 1!
53*6# 
 

*+)%)3*6#&(%
  1!1& Y
- !Y2./ 1# 
5  , 
5!4" 
- ) / (/!5 .52) (1)
- & +
5 % +
- /3!. !
- . .!
5 
Y&  1!!// % 5Y 1!)+)%1 !
.(!%  ".
.(!% -' Y+)%))1!)1 ! 1!35./5.
(1!)1 !) / 2
3/51!$   .2!/ 2(*&.21!
5%!
".) -' % ()./)/&(1+

7.

N

O@D  EF"P  
7.1 1!-))k3/5& ()"&(% ".& 5% -

35.^/ _ "/ )$&.2!4- ".
7.2 -'
 1!)/24 "./&/1)/!53*6#"%.5+!
(k 
5
0''*. /1) ".&&( !-
' 
7.3 1!-')2*(3)&(
(-/1)".!53*6# ?
7.3.1 2*(3)( 1!12) (Controlled Room Temperature) )+ 2
1!)() ,  
5
(()./) 1 1!12)2*(3) 30+2  0,, / 
2*(3 )
5
0'1!)1 /3 &   /%!1!12) 2*(3 )
(  - 
/1)".!53*6# !+() Y 2*(3)
( 0.)* 25  0,, /
(2*(3)( !+ .0+ . %.(!% 23 Y 35  0,, /)
7.3.2 2*(3) - (Refrigerate) . %.(!% 2 Y 8  0,, /
7.3.3 2*(3)5% "- (Freezer) . %.(!% -20 Y -10  0,, /
7.4 /1) 5% ., (Acetone) 1!" -% ( 1!)
3
) !-'/1)".!53*6# (%))+ USP DI
Volume I ". General Notices and Requirements Section ". Section  ! 
USP-NF ".&  ?
8. D D  EFD"L
!( 
8.1 1!)1  ! USP-NF &  (1!)1  !  
  "%  ? +! !%    )
12*/)  3-1)  25!!  )./43
' +)%)1!)' )
1!)1 !)&(-'".&+
5 )12*/)".'*.()
*. ". %1!12)12*3(%! 3
(3   
i ).%1!)1 !  +"% 2*(3) "/ /!% 1!)5
0 231 1!)% 1!)/24 & 12*/) /. 35.
2 `a ".

8.2 1!
5%!. ..... (Beyond-use Date) &(1!
5%!...... 
 . 0 )1!)1 ! /1)&() ("&(%
(  3/ 5 &    ".!/ ! 5  (  3/ 5 3 * 6# /&  -     &  (% 

  Y
53*6# &(% "(%  //&17
 1&!*1!
5
%!. ...!/ 2 3*6# ,) (!41&!*+ USP DI volume I)
 !+&(!1!
5% 
  
5"! ! ?  
. 
5!Y2 5%
5/1)! /&17 USP ". NF
&(
( 1!
5%!. ...+)% 6  !
. 
5 /&- 5% )- ( "1, ! /&17

(&( 1!
5%!.....    . 25  !( % "%+)% 6 
!
1. * ?
() 2%. .!
5
'".+)% 30 !
1!!/'*.% 5Y 1!)+)%1 ! 3*6#  &
!/
.(!%  ".!-'%%
(1+

*   ! +)% 1  ! ".1!)  ) c /  &    +)%  ./

/&-  )
5!4  5% )-  (  "1,/)(
()./) .
(1
"%.)
9. P"F
%C

%C EF
#ST

9.1 35.2

1!35.2()./)"  35."! (/
 )
5) 35."! )
5.+)%&X 
/ +)%  1!)5 % %
^^ ".1+)%" 35."!/5()./&( /)/ + "/ /&(
35./)1!) )
5) .1Y!%".!%35."! 1!
35./ ))k 3/5&
9.1.1 )&(!4&1!)/.()./)
9.1.2 +)%1!&X   1)". 3 )( ,! 

& &
(1!)3 1!)" 12*3 ".1!)/24   " +
&(

9.1.3 /)Y_ /)12*3 1!) "/ /!% ".

0
9.2 2 
9.2.1 &  2
!" ! / 5 _    "/ (  !/   + 
)k
9.2.2 1)(  2
(/(
.2
9.2.3  2
Y2 /),-1+
5
. .!/ ?
9.3 ^$ 1!)$/&( 
   .!
9.3.1 5 ! /&17 , 5/)7 (5 1)
 *
.25 &./  +!$! . )! /&17 ! "%
5&
./ %  5% &5)"/, ) 
5 Syrup USP &./  (
5
&./ & (Sugar-free Vehicle) 
9.3.2 1!)"    %"  ! % 5% &"!
. &())%) 
9.3.3 )*2
9.3.4 
9.3.5 ! ".!/ 2/1!
5%!. .... ( 8.2)
9.3.6 !4-' 
Y
53*6# &(% "(% ) ! /&17
(.25! /&17
5/)7 +)%1!
()51X %$ "1,
(.2)*! /&17
% 1 "1, &.21!)"  //&17% 1 Dose 5% 125 )./5 ). ( 10
)1!!,#/15 ). )#)! /&17 Y&!-) 1!)#$.
&!-) +)%)20 ) 5% 25 )) +)%
5 25.0 )) Y !%&!-)
(
)0 #(20 ) 5% 0.25 ))
$5%! 1!
&"(% (-+5 "./.2 Y35.2-
!%.^+ $".$5%! 
/%1!) $5%!  $".)
1!)
((- % 5

10. (
@D
DC
V
EF

3/51!&/ , .! (1) /&".!4 (2)
  . )/
5 (Batch Records) (3)  ! ".
"'1 )/2*#
5
 (4) "(% /1) ".

10.1 /& ".!4 /)2 ("- .! 5".1!)
"  ! /&17".! 
& )*
5 !4 ".&
110' 5%  )/%!/) 5 +)%+ (Aliquot Method) !/ 2 ( 1!

5%!. ..(Beyond-use Date) ".!4-' 

-'1!12)  )&!'! /&17
*
)! /&17)!%( &1!12) )5! /&1725
/.!
1(
10.2  ! .   /)221  )
 . /)YX),&+".) /
5
  ) .  
.  (Lot Number)
. 5 ".1!)" (Strength)
1. "(% ) !Y2 !)  2% (Lot Number) 
5
. )* ".&!(%!  (Dosage Unit)
. 5/5!/ ".1&!*! 
&
$. 5! * /&(! $.
5. " 
,. !
7. !/ 2/1!
5%!
 . (Beyond-use Date) ".!4-'
10.3 ".'1 )/2*#
5
 1!"'1 )
".2*# )1&".&
1%) % 1% 1
10.4 1!))
5 1+ 
("%
!% )1!)1 !
  3".+)% 1 ".)!

10

11.
D
DC DCP (Quality Control)
11.1 1!12 )12 * 3  /%! (  (  *6#! 4 
  
 !  /2% )!  %   & ( ! 1.(# /   1#  .
/".*2) 
()
!% !Y2 !/2/&(2". +%
!1.(#/)&(
11.2 )51!12)12*3 , )12*/)()./)".)./*#

!/ ". " /.Z 
11.3 &(k 1!12)12*3) 
11.3.1 )1 )2 *#   .& + % ) ./ 43
21+Z[) )(*6#!4

11.3.2 )1%)!41!12)12*3
11.3.3 )!4X+2)"!
 /2%)! % !/
!Y2 35.2 3*6#2 ".3*6#/&-
11.3.4 &!!1.(#)!4!1.(#/&(+!
11.3.5 )/2%)! % !/ ".!1.(#/
11.3.6 )1!12)12*3  ".!Y2
())k
11.3.7 )!/ !1.(#
11.3.8 )&)k!4X (SOP) 1!12)12*3
11.4
*  +)%) (%! !1.(#12*3  1!)&(k
 1!12)12*3) 
11.4.1 )"/% !!Y2".  +  /%!55

!1.(#12*3 (( X315+ )k).

/
11.4.2 )!/
12. (
@(L("

3/5./1/!5% ? +
12.1 )%!/ ! 1)!#    1*.3/50/# ( 

11

12.2 !/ ( //&

12.2.1 &+"%3/5&% ? 5% Remingtonms Pharmaceutical
Sciences; Martindale: The Extra Phamacopoeia; The USP DI; Handbook of Institutional
Pharmacy Practice ". Thai Pharmacopoeia
12.2.2 ".&+"% Stoklosa and Anselms Pharmaceutical Calculations;
ASHPms Handbook on Extemporaneous Formulations; Canadian Society of Hospital
Pharmacists: Extemporaneous Oral Liquid Dosage Preparations; Pediatric Drug
Formulations: Physiciansm Desk Reference; Contemporary Compounding Column in IS
Pharmacist; AHFS Drug Information ". The Merck Index

12

3.2 

 

 $OTF

Good Compounding Practice for Extemporaneous Products in Hospitals
Extemporaneous Compounding (  )0'$. 1  )
/&(! $. " #
( ) " +)%)&(%
  (+)%
)
     )1!)&3/5 )
 ) 0'/&(
! $. 
(+ )1!)))  " ()./) )1!)1 !
 ))./43
' ".( + % Y
E
 $OTF
"!  ) 0'$. 5.  *(*6#
3/5)Y 
(+ Y " ()./) )1!)1 ! )'*.
 3 /)Y )+ % ".!-! /&171 )./43
'  )
( i  1& Y -1"(%  
5!Y2 1!))  ) 1!)1
! ! /&17 &./ 
5
/& &(!/ 2  35.2
".-'
*/&
 ) 0'$. 5  .) 

5 ) *) " #/ %

(! % 1 .& 1!)&! 1!)1 !
".c/&"% /%!  ))
5)*  +)%) )1
1! 1!&0'11!)/&%5Y//2.
/

c&./ )
5  ) 0'$.


 
% &(
 $OTF
 ) 0'$. )(*6# * 
. 0'"  )
. 1!))()./)%1!)1 !"./.!%( 
(
!
1. 0'i )%1!)1 ! 1)". 3 ! /&17
. 0'c/&()./) 5% c&./ )
5
. 0'.! )Y /.! ".!-!
$. 1!12).! !/+

13

5. 35.2".-'Y
,. 0'".&(!/ 2  )
. ^$4 !4
5 1&".&

5 
7. *Y 1!)/)Y
(  ! ".. .!
5 
 ) 0'$. 5. 
(+ )1!)1 ! Y
3 )./43
' !)Y )1!)/.!!-!". % % ) 
! +)%
5!
 (%! 3/5)  1!)(*6#% ? 
Y ()./)))c/&&./ )
5 , ) .  
1. $V
O]#E

H(
"  )0'$. 5.) %( " 5% 
 (Trituration) &
/ (Solution) &"!. (Suspension) &"!.
(Emulsion) ". ?   )*"".1!)1 !  )   1)
".  3
()1!)/.!
 )".
5   ) 0'$.

" &5. /%!
(7%) ) %
" &"!.
2. D HL HLH(
 ) 0'$.
" &5. /%!
(7%&
)-) )" & i7( % ( -1 1!))" # /
5
! "%. "%  &
((%! 3/5) )&(1!))
()./) 
( )
"%.1   ))1!))&( "."
(" #
!Y 1!))  )
( 
( % "./.!%/
5 ".% 
!)Y % %&(!/ 2  )
3. $V
O#^%%  !(D D H( @ID _
i )%1!)1 ! 1)". 3 ! /&17 ".1!)1 !
"  ) 5% !Y2
5 1!))  ) &./ 
5 ) 1!)
% 2*(3) 1!)5 "/  ) .  
3.1 "(%  !Y2
& (Brand of Ingredient)
& ( )-  "(% ( '   %  )  )
0'$. .)%1!)1 ! 1)". 3 ,) 3/50/#

14

  )
("% +  "(%  !Y21!"(% )1!)%5 Y ".
 *!/ 2 !Y2!
3.2 1!))  (Drug Concentration)
 ) 0'$.
" &5.)1!))
"%  .) %  . ". / )/  ! "% 
  1!)1 ! 
"%.1!))-.)1!)%    )&(1!)
)()./) 
 )1 %+-1!
51!))&(21
3.3 &./  (Vehicle)
 ) 0'$.
" &5. /%!
(7%. ) %

" &"!. &+

5 +)%-+!   )& &"!
. Deflocculated System "!
5&./ )/5%! "!.
2%)
Structured Vehicle 5%!
"!.
( . ! % /)&/)  ! % 
c/&&./ )
5  /Y/23-"(% 5)(5 , "%
 5 " "%.")12*/)$.!"%  
5&./ "

 %12*/) 1)". 3 ! /&17 (Active Ingredient)

3.4 /5%! "!. (Suspending Agent)

5&./ )/5%! "!.  ()./)12*/) 1)
". 3   .2 1!)1 ! X .(!% /5%! "!.".
1!)()%12*/) +( /5%! "!.% ? )
5 /%!)
+"% Natural Gum 5% Acacia, Tragacanth (/!)# 5% Methyl cellulose,
Carboxymethyl Cellulose Sodium (CMC) 
5 Natural gum )-+!.  )
-+,)# Oxidase &
( /)/ "..).!  52 #+   
5
/)# 5% CMC1500  )
5
1!)) 0.25%-1.5% /",11
+# / 1.(# ).2 . +
& )1!)1 ! pH 3-11 , 1% !
) mucilage ) pH  ".)1!)/.! %
 )  ()./).

5/5%! "!.
 )&./ )
5

15

3.5 1!)-% (Acidity and Alkalinity)

1!) % i (  /&17) /2%1!)1 !   
1!)) hydroxy ". hydronium ion )% Hydrolysis  ! /&17
 1!0'c/&
() pH ()./)
 Hydrolysis , pH .(!%
5-6  pH ()./) ( 5 /&(/
5 Buffer  pH +"% 25% citric
acid solution ". 0.1M-1M NaOH 
3.6 ,5 (Oxidation)
X ,5)%1!)1 ! ! /&17 / )&
(
,5". (
(
  )
( /2 5% , "/ (.(
!)Y 2*(3)  
 ) 0'$. - *Y / )
/&
1!0(.((/ )% X ,5 5% & 1! Purified
water
/&) Chelating Agent 5% Ethylenediamine tetra-acetic acid
(EDTA), Citric acid )/ Antioxidant 5% Sodium Sulfite, Sodium Bisulfite
( Ascorbic Acid  1!( ,
0 "/ ".2*(3))%
X   ,  5   ) 0'$.  1!2
35. )  ()./)
_ "/ ".-
)2*(3)()./)
3.7 2*(3) (Temperature)
2*(3))%.  ! , .)X  (
/ ! !  %X ) 2-3 %
2 ? 10  0,, /
)+) Arrhenius Equation 1 log k = log A (Ea/2.303 RT)  k : Specific
Reaction Rate, A: Frequency Factor, Ea : Energy of Activation, R : Gas Constant (1.987
Calories/deg/mole), T : Absolute Temperature   1!-  )0'$.

2*(3)()./)
3.8 // (Preservative)
// "%.5.)12*/) 1)"% 
5%! &
( )1!)
1 ! / /
&    pH   ) / / 
5) +" %
Sodium Benzoate 0.05%-0.1% )12*/)
// 
5%! pH 5 (&
!% //  ))5( 1 paraben )12*/)//
5%! pH

16

!  )
5 Methylparaben ". Propylparaben   ) Paraben Concentrate
.! 10% Methylparaben ". 2% Propylparaben .
 Propylene Glycol
 ) 0'$. 5. ). ) &"!.
 +)% )  
51 !)  
.! )  1! ) ! 1 1 )"
5 (Aseptic Technique)  $.  )/&(-"+)%1!
/%//
.'". +
4.
F

 $OTF]#E

'IEHF
(
 )  0'$. 5  . Y  )
 " & "!
. )!4 )"% - )" !Y2! /&17  

)-( 
)-  ( 
( . 
% "! Levigate   % 5 ?
! Levigating Agent &!-   ) Ready-to-use Vehicle /%!(.

( .  % /)&/) ".
(+) 

)-1 (Film Coated Tablet)
 )-1
( . 
% Levigate ! &&!- 
. /%!1)-  "! Levigate ! Ready-to-use Vehicle &!- 
  ) Ready-to-use Vehicle /%!(. ".
(+) 

)-4  ". )-( 
"1,"0'
()&& 
"  )0'$.
5.

%CEF

N

O
 )0'$. 5.
" &"!.1!2
()
!%
! (Headspace in Container)  /&( % 
(+ "%+)%1!)
!%
!()+ , %
0)%1!)1 !  
 35.2
(()./) ".&(
(2
!/5_ "/ ^/
(Tighted-light-resistant Container) %  +)%& -
 - "%1!)"%


 1!)1 ! ! /&17 &(

(-
 - 2*(3) 2 Y 8  0,, /
!Y) Stability Data &(!%  )1!-2*(3)( 20 Y 25  0
,, / 5% &"!. Clindamycin 5.

17

6.

I @'(C
 /2
 ) 0'$. 1 &(!/ 2 
 11!!!))/!5&% ? +&!1.(#".)#+!
"!//2&(!/ 2  )0'$. 5.
(
&(!/ 2  .*!!% )*! /&17)
1!)" ( !% 90 %  1!)"   &(!/ 2  )0'
$.
" &5.
( (.).!
()1!)/  /2
% +)%)./43
'  
. &(5%! !/ 2/!%(%!/ 2 )/
!5
5//2 1!))

./43'  )
. &(!/ 2+)% 30 ! !/)  ")  5.)
)!5//2!/ 2 !!%-)  )! +  /)
("!

! "%.1 .)^^35. )%1!)1 ! ! /&17+ !

)-' 
 -)2*(3)+)%+)&(".Y- &"!.
 )0'$. +!+."%   (Caking)
&(!/ 2  )!+.
51&!% Expiration Date "%
/&(&  )0'$. ))//2+)%)1!
51&!% Beyond-Use
Date ( 1!
5%........
7.
#ST

$^!  )0'$. 5...25! 5! 

/&17 1!)) ! /&17 !4.  !".%  !/ 2
!4-'". %!%
5 
 ) 0'$. 5.  )
)* 
5

. .!/ "%! &
5 
. .!!% 30 ! ) ) 
 0'$. 1 .) ? 1! !  
( ! +  + . 
(
   
5 1&  ()" # / .i 7 (  /   2 %     !
. 1&(    ) 0'$.
" &5.

'*. Reconstitute 1 "  2 !  !( !/5
/%  %
 "(

18

!/ !2&./ "()./)  )!  

5 
(/)
 "( &./ 
( ,  ".&!  !4/) ".
5 
 " +!
$  .2
(Y !/ 2 ".-'( !/) "!
c/&  )0'/&(! $. 5. )

5)*) 1!&0'! 1!)1 ! ! %  ) 0'$. )

1!)/&17
'".)
5% 1  /Y/23-"(% 5)(5 5%
2%) j%5!*1 2%) 1(!
".1!)(  /%!/&)
5
+)%)1 1!  0'!!)) 
5//21!)1 !  ) 
/%!
(7%&(
(-  )0'$.
 -2*(3) 2 Y 8  0,, /
8. (
@D
DC

 ) 0'$.   )) . +&(+!
/
1!12) "%.5%
/1!12)) . " +! 5%
5  5 1 1!)"  
5  !  Y2  & ! 
5  )  )  )
"  ) 1!)) /&&./ 
5 !4 ) $".&

5  !/ 2 -' ".!!*) (Literature Review) % ?
@C#
 ) 0'$.
" &5.  "
)-
(+ &)1!)))  /  1& Y 1 1!)1 !  )
./43
' 1!)3 ". )..12*3  ) 
 )c/&".!4 ) % % , !)Y c&./ 
)
5 ) 0'$.  c&&./ )
5
()(
" "%.")12*/)$.!% /)Y
5
(()./)12*/) 
"%.5 1!)/.! % !-!% ) + )1!)1 !".)./43

'  1!0'(1!)1 !  ) )/)"!) 2/) 
c/&/)Y'1!)1 ! ! 
()./43
'+!+
 ! /)Y( +1)&(!% / 2 !)Y .( 1%
5%
. 5#
'".1!)3

5 

19

3.3 

   
   
 @((&( I @I 
]L #`  
TF

Good Compounding Practice for Parenteral Nutrition in Hospitals

 )/( (&/&(! $. . X)

(*6#!4 + &(+! 
(
5/( (& +/(
)12*3)k )()./) ".)1!)3

5  
1. @A (Aseptic Section)
1.1 &(
(+))k/Y 05  1!" 
. )  5% Cytotoxic Drug
1.2 *+)%/)Y&
((  )/( (& Clean Room
+ 1!)( /." )//%!
1.3  ) .  )3
 Laminar Air Flow
2.
CD
 (Personnel Sanitary)
2.1 21".(X  )12*/)+)12*/) 21
)/ (*6#!4 
 +)%
5% 05
    2
21
2.2 &  ((   " .1!)    5   (      !     )
/( (&
"%..  '*#' (  )
/( (&  )3/5 %  1 1
2.3
()/".Z[)( !  )/(
(&
115 (Aseptic Technique)  % % )1!)
()./)
3. D&( &(EF(C#
 (Equipments)
3.1 2*#".1 ) %
(  )1!& Stainless Steel (!/2+)%
% /
(/ /% ? `a+
3*6# ".1!)$.&
%
3.2 2*#".1 ) &1!)/.+ % ".+)%/./) Z2 (
51

20

3.3
()&2 '2*#".1 )% ? ). .!&( ".
+!(k
3.4 )  !/./  4 3  1  )  &    5%  1   0
(Laminar Air Flow)  !1!)-!) (! Plate /`a 
5". +!(k
4. H '(H(
 (Process)
& )/( (& /&(! $.  )
& ( &    %  5  21    !   +  ) ) 
./  % 
/%! " #   3/5 
(+/( )
12*3)k)&(
4.1 )!/ /(
(  (&  . )/& (  !
$.
4.2  !  ) X).!.2+!2
 "
 ? .!  .2+ !  +  2 )    5 
 '*# '
4.3 )!/1!)) 1 ) 1!)Y  !Y2 "./
% ? %21
4.4 1!12)12*3.(!% 
!*  +)%/ %12*3
/( (&
(`a 5+
4.5
.(!%        _  (  $ "/ Y  ! 2  5  
5

.! ) ().&/)Y_ 1!)// ! "%.
5+
4.6 ))()./)
_ `a
.(!% 
4.7 /)/(  )&/).2+!
/&(
4.8 (   ^$
*+)%/)Y&+  )!4
()./)(_ //(^$
4.9 ! 25)"%
5  ).2! ! ^
5 &( 2 +!
$ ".-
/3!.()./)

21

4.10 )1!12)12*3!Y2
- /335.2 ".((%
- !/ 2
- Clarity Test
5. (
@ (Document)
//%!/&17 ..12*3 ,  /1 (*6#
! 4   
 )/(
(   (  &   ) 2  ./ 1#    &  (
 .  !  "!
X  ".1!)

X    /)Y!/)
 )
*% ( )
i7(




5.1 /& +1!)(-5 5%
5.2 / )1!)5 " ".& % 5

(!/+ %
5.3 1!)!2 /
(/)  %/)


  

- Standard Operating Procedure (SOP)
- Batch Production Report
- $

22

3.4 

 

  O!(d@I
]L#`TF


Good Compounding Practice for Cytotoxic Drugs in Hospitals
(  *6# ! 4   
 )  ) ' %  ,# /& (    ! $.

   .!1!12)"..12*3 //  )'% 
( ).- ,  )/&(! $.
 ) )'%,# (Cytotoxic Drug) . )(%! 5 $.
/Y   )  )  .1!12 ) 1!)/.3
(  ".._    
"%. . /%3  /&(.! ) 
5115
(Aseptic Technique)  .!   ) 3
 Laminar Air Flow Hood
5 Vertical _ `a (Contamination) ".1!)3   )
1. @A (Aseptic Section)
1!" /Y ) )'%,# !* ) 
1.1 1!12).0
1!" .0/Y ( )  ?  -

!* )   1!12 )1!) 0
(" %     !* )  %
()./)  /%!* )  X  ".!/2/  % ? 1!%"#-
(Air Lock) 0% /%!* ) 1! % Prefilter ". HEPA Filter !)
0".0Y()2! )
5 1! ./77*
*
.1!)0/ ".1!)!/.1!)0"../77*
. . ? )+!(k
*+)%/)Y&
((  )  Clean Room +  %  . )(
" )//%! )1 0 (Air Condition) ()2! 0
(
 )  "."'1!)/.
(  ) . & /)&/) 
(+
(  ) /./2
1.2 !* ) 
 )   &3
!*_  %X     )
3
 Laminar Air Flow Biological Safety Cabinets (Class II ( Class III)

23

2.
CD
 (Personal Sanitary)
2.1 /2) /%!211
2.1.1 X  )/23 ())3!.-! /)13#
& . 13# (
()2 X  !  )  %! )()2! 
( )  %  2 6 
2.1.2 X ".  )5) . /!)2*#_ !
) .2 + !
 !* X   "%  ."(%  2 *# _  
5 + " % "!%    3
52X _  Y2 ) !) 2*#5%! (

2.1.3 ()/!)52X !* ) 
2.1.4 X +)%1!
51 /& "./!)1 . *.X 
2.1.5 () .(  1 ! &) /2( (-
(+!3
!* ) 
2.1.6
(X))k% ? &(+! % 1% 1
2.2 !/23
2.2.1 Baseline Examination 1%. )! Baseline +"% 
! (CBC), ! Biochemistry 5% Liver Function Test, Urea, Creatinine,
Electrolyte ".! Urinalysis
2.2.2 Routine Examination ! ( X,& , 
!.&+
5" 21)) 1% Baseline  21(%
. ( &  !  1)& !%!/,&.!% 
!/%3!. 1!& Routine Examination  %  2 6  ".)-)
!+!
 Medical Record  21"%.
2.3 )
21 !  )".(  )'%,#  +Z[)
11()./) 21 %!.! 3/5 0'3/50/# ".21
Z 115%!  ) X   21 !  .).!  
2.3.1 X)
/ )  )'%,#

24

2.3.2 !4X

  (Worksheet) ".! /
5

. /) 
2.3.3 X /%X 
!*( /.
(Clean Room)
2.3.4 &  Laminar Air Flow
2.3.5 &1!)/. ".& . )'%,#  %
".( .! ) "5 (Aseptic Procedure)
2.3.6 -'"./%  )1)&
 1!).)1!)".1!)/)Y X . . ?
".+!(k
3. D&( &(EF(C#
 (Equipments)
3.1 1 )".2*#
5
1 )".2*#% ? 
5
!* ) )'%,# 1!" +!

!* %!% ".+)%1!&+
5
!* )  ? Y&
52*#,
!+
5
!* )  ? . &1!)/.2*# %  &
4 `a%.1  !* %!
3.1.1 Syringe ".522*# ) 1)& !) 522*#

(  1!" Luer-lock _ ( /   Syringe 5.)
'*. !, . Lock -)
3.1.2 -)
5/. 1!
5-))
(7% (# 18 ( 20) 5%!
1!)/
" / ?
 Syringe -)# )

5 ) 1)& 
1 -)) +)%-!%# 21g/1.8 mm
3.1.3 2*#
5 ) 1)& 1!"
5"! (/
, 1! (  ) /- ( () 1)&(
3.1.4 1!! Plastic-backed Paper Liner ! Biological Safety
Cabinet (BSC) 
5 )  _  1)&( BSC ".1!  Plasticbacked Paper Liner (  ) /-"%.! ()) 1)&(
3.1.5 +)%1!2 
 Syringe
())*2 Syringe

25

3.1.6  )/-"!1!2

35." Zip Lock ".$!%

3.1.7 1!)35. /) 5% Y /)Z^ !"!
)Z^ (Y(.)Z^ 1! )2*# %!+!
 BSC %)X 
3.1.8 Syringe !&".! 1)&  1!$ 5 !
(! 5    ) () !4( /-!
(  !/!
 ) !/ 2 ".!4-'(   +)%Y
5
3.1.9 Syringe !& ".! 1)& 1!$
(!%
 1)&.!
3.2 2*#
5/&(X  (Containment Equipment)
&!/&  1 Biological Safety Cabinet (2*# ?

5/&(X )+)&(% *1  2*#++!
!*
1!&/./43 1 %
5 
()% 1!&!/./43
 1  %  d. 1 1
3.3 HEPA Filter
 HEPA Filter
" Bay-in Bay-out , /)YY  "%
 /+  "% ".%/ +)%/)/ 03  Y+)%
/)Y HEPA Fiter
" %! 1!Y "% / %
.).! ".-+!
Y2 / ( ^Y2 /"!
(
/%Y2 /
5( ".^5% ! ". $Y2 / ^"! .2 1)
&  )1!)!% &+&   2*(3)/
4. H '(H(
 (Process)

 ) )'%,#. Y  ".X %+

1) !%! /23".1!)3
2) 1!12)!/ 5%  
(! !%()./)(+)%  ) 
Y  )5  ./% /Y ) +  ! !% +)%)
`a (Contamination) (!,) (Leak)
.(!% /% 
3) !4&  % 3 ! 11Y% /5 "%.1

26

4) /( (Spillage) ". . (Disposal)

 ) 1)&
5115 (Aseptic Technique) 
(!
+3*6#)12*3 5 11  _ /)/   ) +!
5. HL(DF 
  (Precaution)
5.1 !4X) (
.  521 )2(2 %! ".  %

!* %!
(() ".&1!)/.!* %!
5.1.1 )*  * &Y)(&!-  5-
("( !
,)+ 5% ( Y  &!-
(5-! d ((
d  ".1!5-&1!)/.!* ( %  3 1
5.1.2 )* ) 
5.',( 5((),
& + "!5-&1!)/.!* %!! & &1!)/. "!)! &
/. !/2
5&1!)/.`a  () !!)
/%Y2 ".&+&  
&2*(3)/
5.2 !4X)+/)/ 

*X/)/  +)%!%.% Y2 )(52X  /!)

/% (
/)/  !*( (.-  X ) 
5.2.1 YY2 )(52X /!)
/%
5.2.2  !( /%!/)/!  ! &)*) ? Y/)Y
5
/. &
( (Neutralizing Solution) + -
(
5 !( /%!/)/! 
5.2.3  !( /%!/)/! ! /%".&
5.2.4
* 
( ! &)*) ?
5.2.5 /%
(" #!
2  1     (2  *#  %  ! .      +!    (  k".    +!

!5.  X !

27

6.
% 
N
 O!(d
6.1 " - "%.5 "..2!*-
(5
6.2 )-3 ". -
(()./) ( "(
!,) ! 
7.
H@!
7.1    )" ! .    - 
35. %     _    " ! ( 
`a
*./% +  (!
7.2  ^$1!) 1)& .).!
8.

I% HF##ef( O!(d
 .`a )'%,# ".!/2% ? )`a  -
35.
^ /  , & 1  () "/ !%  /1)     .&    35.^  / 
 %! &  2*(3)/ 1,800-2,100 F ( 1000-1,200 C
9. g@I
#h
  (Standard Operating Procedure)
1!  & )k/&  ( ! 4  X       '*#   '   _    +)%
(
X/)/!  )k/&(!4X 1!& 5%
9.1 - Stock 
9.2 ./%
/ (Order) 1)&
9.3 .! ) 1)&
9.4 /!)52X ) 1)&
9.5 &1!)/.(  ) 1)&
9.6 /% 1)&
9.7 &1!)/.)35.2) "(`a) ".
&  !  ".!/2`a!  %!
9.8 &1!)/.2*#  ) ".5/%!% ? 
5
9.9 !4X)(2
9.10 &2 '1 )
9.11 - (  )
9.12 11 )  

28

3.5 

 



Good Compounding Practice for Ophthalmic Products in Hospitals
 )  3/5
    )3*6#05

* +)%)&(%
  3*6#(%
5 (  ($

(5% Intracameral) ". %
/. & "!. (
/ /&17
 ) 
   +"% 1!)05 , ._ 
5"./7/ 1!)/)Y
) (- `a5

.(!%   ) 1!)Y 
1& !*". )  (  
Subconjunctival ($ ).)5%!  '"1 ()1!)
 % 2"
11 )/. 
5
" !"! &
( )1!)) 
) 2 %1!))   (++1!/ ,3*6# 
+27. & 
(
  
("%
!% 05 )1!)
1 ! ".1!)+ 
(*6#!4
  
  %+"! 3/51!
&+X )&  )3*6# 
   "%+)%/)Y&)
5
&(".1!12)12*3
  2/()
1. %
5/1)
 )  3/51!!/
()
1!)/)Y&)
5&( 3*6#.(   Y+)%)/
(
) 3/5 0 1!)5&7
 3/5)
.)1!)()./)
3*6# /&((  %
2. i /&17
/
 )3*6# .!
1) 1!)05
2) Tonicity
3) pH, Buffer
4) 1!)' 
5) 1!) 
5//
6) 1!)/)Y
.
7) 1!)1 !
&./ ()./)

29

8) 1!)(
9) 2((% ".-'3*6#
3. )/"/ /&(/)/%!. /1) "%.5 ".
-
+ % !4 ). "/  . 2 !) 110
5 ". 5 (&
(05
/2 5% Autoclave
4. %) )3*6#  1!!1&!* !/
2 1 1  ( 
5 ! 4  
1&  !*  1!)  
( )    /2  ! 4   )
1!)/&17/&(  5% $
 , ) 
5 ". 
( 1 1!)
.0 )
 )3*6#(%&
(
)) % 2"
5.  ) 
)*)./)Y5 ! +Y 1!),
1!)+)%")% &5 ! !
)* ? "% .! /)
( 
+ % /)&/)  $. ) 
6.  Y115(&
(05 % 1% 1  
/%!/&17  )   )3*6# . &
 Laminar Air Flow
(( Isolator ( Biological Safety Cabinet, BSC)  )  )Z[('.
".)1!)5 !57
 )  X)(1!12)12*3  ) 
05
   ".&( 1!)Y
.!2

 )3*6# 1!)* 
(1)
 )  1!/)/% ?
35.%05 /.
"%.51!
/%
 Syringe "   1%
/%!)
 Syringe 
(7%!% , )
 .2/%!/) ()+  / -)+
 Syringe
(7%+)%
)-) %
(2) 1!)Y
5 ! 1!.
5 syringe -/2
2
)/%!/)  Y+)%)) +)%1!.&..)*)
(5% Y ) 4.5 ml
 Syringe  5 ml "%+)%) 4.5) 1!
5
Syringe 2 ))5"

30

(3)
5-)". Syringe 5 Disposable  1!
51  !"!
2
( `a"._ 1!)/(1
(4) Y & ( 1 1!. $ (Label) +!35.2
5!1!! _ //
(5)
 )   Sterile Powder  &). &%
5 (
 (! Ampule 1!&/%!/) ()) % Filter  5 &0'
% ?
7.
*  ) 
(05 1!!4&
(05
".!/1!)Y     ! 4  & 
(  05     12 * /)   
3*6# ".35.2 !4&
(05 ) 1  % Filter 
0.22 m 
35.2/2 Y&
(05"!  % +-)!4+)%()./)
 )'*. &"!.".  ) ) /%!/)  +)%+
&
(05. &3*6#/2 )&
(05%.&+
5
! &
(05 Autoclave 3*6# 
35.2/2 "%
*!%3*6#)1!)1 !( % Autoclave (+)% ".. )1!12)
12*3.(!%  ) ()./)
8. +)%1!
5//
&$+
 (Intraocular Injection) .
//  5)'%1 / 3

9.
 )  Cytotoxic Agents (/  ? 3/5.
(1!)3
& /1)(%
10. 35./2 2  )1!)()./) ".+)%1!.)%1!)
1  ! "../  4 3   ( 5  /)Y2
!/   & 
(
05"!  5)2/&(( 
!(52(( "  
5 1!.Y2
(/&(2 &
(05"! 5$
+)%+
5(  )/- 1!.2
 Sterile Vials )!%.2
 Syringe
35.2 % 1!.)^_ `a
11. 3/51!.&(!/ 2   ))1!)1 !
3*6#".1!)++ `a 2 # !  1!)1 ! 1)

31

 /%!/) // ".35.2 1!&)* .)1!)1 !
3*6#  ()
12. $  ) 5".Y
 *$  ).
.2&( 1!)) //&17".// ! $-1!..2!4-
 Handling ".!/ 2
(5 . 
  $ %
(! 
( % 
(/1 
HL(DDIVAV
 @F
i  !  )/.  ) %+
1. 1!)
/ (Clarity)
 0Z2 ") 
5!4 
(
/ ()/&
(
/
(Clarifying Agents)  5 5% 1% Polysorbate 20 ( 1% Polysorbate 80
2. Tonicity
&/. Isotonic  % 0.9% Sodium Chloride Solution  % +
-) 1!)) /)Y+ 
% 5%! 0.6%-1.8% /)) # Sodium Chloride 
 5 Hypertonic  )! 
)*/  Hypotonic 1!)
/ + tonicity
(+)  /%!
(7% )
5 Sodium Chloride, Boric Acid
( Dextrose 1!)%  1 300 mOsm/L ( %
5%! 200 Y 600 mOsm/L)
3. pH/Buffering
1!
5/1!)%
)*  
(& pH /%/3!.
( ( "!  !+1!
5) Buffering Capacity  !% 0.05
1% pH ()./)/&( 1 4-8
4. 1!)05 (Sterility)
/. &
(05+ % ?   ! Sterile Membrane
2 0.45 ( 0.2 +)1 !4 ? 1 Dry Heat, Autoclave ( Gas Sterilization
(Ethylene Oxide)
5. / (Preservation)

5( ? 1 1!)// )1!)()./) ". +
//&17
&

32

6. /,5 (Antioxidation)

   ) /  ,  5 
  3 * 6#    ) 1!)1  !
(   
/,5
5
  5% 0.1% Ethylenediaminetetraacetic acid (EDTA), 0.1%
Sodium bisulfite, 0.1% Sodium Metabisulfite ". 0.1% Thiourea 
7. /)1!)( (Viscosity Enhancers)
)1!)(.&
(/. 1  %
+ ). .!
(! 
 ,) + ! 1!)(    % .)* 25-50 cps ". .   1
/
( 
/%/)1!)("! /)1!)(
5 0.25% Methylcellulose 4000,
0.5-1% Hydroxypropyl Methylcellulose ( 0.5-1% Polyvinyl Alcohol
8. 2 (Packaging)
1!2/. 
!)(( 05("% 2 
"%. Dose
 Syringe 05".+)%)-)

33

3.6 

 
  
 %
@ C 

Good Compounding Practice for Herbal Products in Hospitals
/)2+!Y2.0+ +  1!. &c/)2+
  
5             .0+ ".2  1  
% .0 ).)*!%1". % ? 5%    b_   + -1
1!( (% ))1%  &
d 2542 .)* 5000  ". 1!)
 "!  % ? ) ) /)2+
" &! Mixtures  %
"! , /%!
(7%"! (% .)'*. Low Dose ". Large Volume    )
/)2+
    +)%
5%  (++)%+ .i2) 
/)2+( 5 %
75 ("(% 5    /)1!  % ? 1!)
 )  )/)2+ 
75 ("(% 5
g
%
@ C
3*6#/)2+%  "i2 , ). )// 1.(#
 $.11".!4 3*6# /)2+ )!Y2+5 ,
).)) `a )1!)"%
 - ! "( - !
" , )%12*3  
/%! ./43".'*.3 
   / /&17)/2  ) /)2+ 1 "12*3
!Y2)+".!".1!12)12*3
1. @A
1.1 !*-
!Y2/)2+1!)" -
!*$. ). 0 %  )
_ /!#".")  $./!#)bi".  )!/)./43
+)%
()  ! 25) %
!Y2/)2+  )

/%0'

1!)/. 1/Y-'!Y2".!* ?  $.Z2. /%!
&(
-//  # /1) /%!.
&  35.2 ".
$  )/)2+ )/&-"! )&(5% ! ) !+
+)%
5% 05

34

1.2 !*&
5% ! !+   )"&1!)/.".( 
`aZ2. 1!.! 0'.(!% /2%)! % 5 &( /) ".
.! /)2+ .! Z2. ".`a
2.
CD

 )1!)1!)5&7 ".X!5% !21

 )  )!+ "% ))  /)2+)) 1
2.1 


 : 21
(%! 1!12)12*3  )1!)5&7

 !Y2/)2+/3*6#/)2+ /)Y!/'*# !/`a
% /  /+)%/)&/) !Y2/)2+ )1!)
&)k/)2+
 
5
   ".      '*.3
 3    '*.3
   
20#".1)bbd
2.2   : /2%)! %  21)1!)5&7/)2+
/2%)! %
(X)".&
 WHO Quality Control Methods for Medicinal
Plants Material 1992
3. D&( &(EF(C#

"  ) Y %
" & 1)   1+)#(
  ,  .
5  1  )  5%  !  )  ! + "% Y  ( ) "1, ( 
. )1 ))) "%.   "%)(" -'
2*#5% !  )!+ /&171 /."."(
4.
% /%   AC
 @ C
4.1 &1%)
 )!Y2"%.5 ))k".-
 ! 5%  2- !  (   ((% Y /%.!
 )/+!  2.!".!4./% %12*3 
& &+!/) !) "(%  . & .
".- ! )1!)& %   5 )* ".!&- !
5 ? !) /1)"./ ? 
5.(!% . 5% 2 j%")
4.2 - !21  )$&".)

35

4.3 !Y2%  Y./)!)  ).!%   /)
 ! 
/) )/ !
4.4  .(!% !Y2/)2+"., .  '*# '/)
5% +!
/&(12*3 /   )
) !3)0/#( /30(/!#!
5%!  - !
+!!
4.5
(0'"%( (  ! 5/)2+ +)%!%.5%!
. (
.!
()1 !)
12*/)% ?  /)2+".


11X 
5. HL(EFI
 %
@ C
5.1 1"(% "./)2+)1!)/&17 % )  1
 %  +)%1!,!Y2/)2+"(% +)% %  1!,
'*. Contract
Farming 1!12)12*3 ".! "

5.2 /Y-!Y2/)2+ /. ?
5.3 +)%1!,!Y2/)2+-+!! +)%&
5.4 /)2+ 5) 5% ).)_) ) 12  ! "

,
6. (
@
6.1 12*'*.) !Y2
 )&( !Y2&)& /)2+ .2
/ 
- 5'0/#
-  . "(% ) 5
- !4&
("( "."
- '*.3  !Y2/)2+('*.3
 20#
- !'*#()./) 1!!//./&17 %
"! (!/ Markers ( TLC Finger Print

36

- !1.(#!Y2))k Thai Herbal Pharmacopoeia (

Pharmacopoeia  % .05Y+ Y+)%) &)k /)2+"%.
5+!
6.2 &( 3*6#/&-
!/
51!12)3*6#/&-
()/4)&( 

5 12*3".5 )* Y/4
(!1.(#)*/4 Y+)%

(!1.(# Markers " (1!12)12*3 ()*// (extractives)

!
&. (solvent) 5% ? !'*# %  1!& TLC Finger Print 
!Y2/)2+".3*6#
*+)%//&17 /&(&( ?
(+)
)k 
" ? 5% Y &!+
53
)&( 2 #

)*%
-
( Y)
6.3 1%).! 1!12)12*3 /1!)1 /3 ".
/2%)! %
1!) 1% )  5       ) ! 4  X   5  2      )  .2
 1# .% ? 5% 1 ) !/2 !4  % . 
"% .! Y2 /)2 +( 
3*6# ".)X 21  )/1!12) ". 
5% !  )!+
7. DI$  (Glossary)
Markers () Y /% !. /)2 + , ! % 5".
5
1!12 )
)k /)2+  !+ Marker ./))*)(!1.(#+ % ".)
1!)/)4#//&174 /)2+ ?  //&17))* ()!4
!1.(# 2% 
5 Markers .)12*3 !Y2(3*6#/&-+ 
5
Marker % )*

37

38

39

74